30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Pacs Group Inc (PACS)

Track

Recent insider activity at Pacs Group Inc. shows a significant net sell volume over the last 90 days, totaling over $14.8 million. Notably, Mark Hancock and John Todd Mitchell have engaged in substantial proposed and planned sales. The company's stock has seen a modest 3.6% increase in the past 90 days, trading near its 52-week high.
Stock chart
Ticker: PACS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hancock Mark
Co Fndr; Exec V Chair
5 sales — total 500,000 USD
Planned sale 17 Jun 2026
Value US$3,963,710.88 | Price 234.19 | Shares 20,190
Planned sale 17 Jun 2026
Value US$1,520,494.91 | Price 149.92 | Shares 44,626
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 35.28 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 35.28 | Shares 1,000
Proposed sale 17 Jun 2026
Value US$100,000.00 | Price 35.31 | Shares 1,000
Planned sale 16 Jun 2026
Value US$419,478.60 | Price 65.40 | Shares 73,846
Proposed sale 16 Jun 2026
Value US$3,987,288.92 | Price 492.57 | Shares 68,882
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 37.88 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 37.05 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 36.23 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 36.34 | Shares 1,000
Planned sale 18 May 2026
Value US$125,440.59 | Price 38.01 | Shares 3,300
Planned sale 18 May 2026
Value US$892,251.74 | Price 37.04 | Shares 24,089
Planned sale 15 May 2026
Value US$263,977.09 | Price 38.74 | Shares 6,814
Planned sale 15 May 2026
Value US$1,742,036.87 | Price 37.91 | Shares 45,949
Proposed sale 15 May 2026
Value US$3,310,277.60 | Price 41.30 | Shares 80,152
Sale 13 Mar 2026
Value US$1,245,647.37 | Price 34.28 | Shares 36,335
Proposed sale 9 Mar 2026
Value US$1,223,762.80 | Price 33.68 | Shares 36,335
Buy 24 Nov 2025
Value US$499,997.43 | Price 29.90 | Shares 16,724
Sale 24 Nov 2025
Value US$4,768,378.93 | Price 29.89 | Shares 159,556
Proposed sale 24 Nov 2025
Value US$4,387,790.00 | Price 27.50 | Shares 159,556
Sale 9 Sep 2024
Value US$294,652,760.00 | Price 36.25 | Shares 8,128,352
Sale 9 Sep 2024
Value US$294,652,760.00 | Price 36.25 | Shares 8,128,352
Sale 15 Apr 2024
Value US$33,749,982.00 | Price 21.00 | Shares 1,607,142
Sale 15 Apr 2024
Value US$33,749,982.00 | Price 21.00 | Shares 1,607,142
Buy 11 Apr 2024
Value US$9,992.73 | Price 23.08 | Shares 433
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-17 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
20,190 -17.4%
234.19
US$3,963,711 		20,190 -17.4% 234.19 US$3,963,711
2026-06-22 2026-06-17 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
44,626 +32.4%
149.92
US$1,520,495 		44,626 +32.4% 149.92 US$1,520,495
2026-06-22 2026-06-17 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
35,335 +5.9%
323.77
US$1,464,519 		35,335 +5.9% 323.77 US$1,464,519
2026-06-22 2026-06-17 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
1,000 -0.1%
35.28
US$100,000 		1,000 -0.1% 35.28 US$100,000
2026-06-17 2026-06-17 PrS Proposed sale
2.4
Hancock Mark

Officer; Director; 10% Stockholder

Executive Director Large shareholder
1,000
35.31
US$100,000 		1,000 35.31 US$100,000
2026-06-17 2026-06-16 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
1,000 -0.2%
35.90
US$100,000 		1,000 -0.2% 35.90 US$100,000
2026-06-16 2026-06-16 PrS Proposed sale
2.4
Hancock Mark

Officer; Director; 10% Stockholder

Executive Director Large shareholder
1,000
35.90
US$100,000 		1,000 35.90 US$100,000
2026-06-17 2026-06-15 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
1,000 -0.0%
37.88
US$100,000 		1,000 -0.0% 37.88 US$100,000
2026-06-17 2026-06-15 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
1,000 -0.0%
37.05
US$100,000 		1,000 -0.0% 37.05 US$100,000
2026-06-17 2026-06-15 PlS Planned sale
2.4
Hancock Mark

Co Fndr; Exec V Chair

Executive Director Large shareholder
1,000 -0.2%
36.23
US$100,000 		1,000 -0.2% 36.23 US$100,000
2026-06-16 2026-06-15 PrS Proposed sale
2.4
Hancock Mark

Officer; Director; 10% Stockholder

Executive Director Large shareholder
1,000
36.34
US$100,000 		1,000 36.34 US$100,000
2026-05-19 2026-05-18 PlS Planned sale
0.6
MITCHELL JOHN TODD

Chief Legal Officer & Sec.

Officer
3,300 -0.4%
38.01
US$125,441 		3,300 -0.4% 38.01 US$125,441
2026-05-19 2026-05-18 PlS Planned sale
0.6
MITCHELL JOHN TODD

Chief Legal Officer & Sec.

Officer
24,089 -2.9%
37.04
US$892,252 		24,089 -2.9% 37.04 US$892,252
2026-05-19 2026-05-15 PlS Planned sale
0.6
MITCHELL JOHN TODD

Chief Legal Officer & Sec.

Officer
6,814 -0.8%
38.74
US$263,977 		6,814 -0.8% 38.74 US$263,977
2026-05-19 2026-05-15 PlS Planned sale
0.6
MITCHELL JOHN TODD

Chief Legal Officer & Sec.

Officer
45,949 -5.2%
37.91
US$1,742,037 		45,949 -5.2% 37.91 US$1,742,037
2026-05-15 2026-05-15 PrS Proposed sale
0.6
John Mitchell

Officer

Officer
80,152
41.30
US$3,310,278 		80,152 41.30 US$3,310,278
2026-03-17 2026-03-13 S Sale
Jergensen Joshua

President & COO

Officer
36,335 -1.3%
34.28
US$1,245,647 		36,335 -1.3% 34.28 US$1,245,647
2026-03-09 2026-03-09 PrS Proposed sale
Jergensen Joshua

Director

Non-Executive Director
36,335
33.68
US$1,223,763 		36,335 33.68 US$1,223,763
2025-11-26 2025-11-24 B Purchase
3.2
Dilsaver Evelyn S
Non-Executive Director
16,724 +278.0%
29.90
US$499,997 		16,724 +278.0% 29.90 US$499,997
2025-11-26 2025-11-24 S Sale
0.6
MITCHELL JOHN TODD

Chief Legal Officer & Sec.

Officer
159,556 -17.4%
29.89
US$4,768,379 		159,556 -17.4% 29.89 US$4,768,379
2025-11-24 2025-11-24 PrS Proposed sale
0.6
John Todd Mitchell

Chief Legal Officer

Officer
159,556
27.50
US$4,387,790 		159,556 27.50 US$4,387,790
2024-09-10 2024-09-09 S Sale
2.4
Murray Jason Hulse

Co-Founder, CEO & Chairman

Executive Director Large shareholder
8,128,352 -15.3%
36.25
US$294,652,760 		8,128,352 -15.3% 36.25 US$294,652,760
2024-09-10 2024-09-09 S Sale
2.4
Hancock Mark

Co-Founder & Exec. Vice Chair.

Executive Director Large shareholder
8,128,352 -15.3%
36.25
US$294,652,760 		8,128,352 -15.3% 36.25 US$294,652,760
2024-04-15 2024-04-15 S Sale
2.4
Murray Jason Hulse

Co-Founder, CEO & Chairman

Executive Director Large shareholder
1,607,142 -2.5%
21.00
US$33,749,982 		1,607,142 -2.5% 21.00 US$33,749,982
2024-04-15 2024-04-15 S Sale
2.4
Hancock Mark

Co-Founder & Exec. Vice Chair.

Executive Director Large shareholder
1,607,142 -2.5%
21.00
US$33,749,982 		1,607,142 -2.5% 21.00 US$33,749,982
2024-05-13 2024-04-11 B Purchase
3.2
Millard Jacqueline
Non-Executive Director
433 +inf%
23.08
US$9,993 		433 +inf% 23.08 US$9,993
Explore more

More insider trading research around Pacs Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America